... Next-Generation Antipsychotics“Next-generation antipsychotics” is not an official FDA classification, but it is widely used in clinical and academic literature to distinguish these treatments from traditional dopamine blockers.Xanomeline and trospium chloride (Cobenfy) is the first next-generation antipsychotic, approved by the FDA in September 2024 ...
4 First-Line Treatments for Schizophrenia: What You Should Know
... Next-Generation Antipsychotics“Next-generation antipsychotics” is not an official FDA classification, but it is widely used in clinical and academic literature to distinguish these treatments from traditional dopamine blockers.Xanomeline and trospium chloride (Cobenfy) is the first next-generation antipsychotic, approved by the FDA in September 2024 ...